Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H39NO3 |
Molecular Weight | 401.5821 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C)C=C2)C(=O)O1
InChI
InChIKey=MVCQKIKWYUURMU-UHFFFAOYSA-N
InChI=1S/C25H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-28-25-26-23-18-17-21(2)20-22(23)24(27)29-25/h17-18,20H,3-16,19H2,1-2H3
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1812 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18500680 |
5.95 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16953261
60 mg three times daily t.i.d., 120 mg t.i.d. and 240 mg t.i.d.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29715
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2103825
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
UU-75
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
C77404
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
C520092
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
8461
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
m3290
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB06586
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
LC5G1JUA39
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
DTXSID90182506
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
100000175675
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
CETILISTAT
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
282526-98-1
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
4886
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY | |||
|
9952916
Created by
admin on Mon Mar 31 18:33:32 GMT 2025 , Edited by admin on Mon Mar 31 18:33:32 GMT 2025
|
PRIMARY |
ACTIVE MOIETY